Fluorouracil
Fluorouracil is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Fluorouracil; Generic name: FLUOROURACIL; Drug class: Nucleoside Metabolic Inhibitor [EPC].
| Brand name | Fluorouracil |
|---|---|
| Generic name | FLUOROURACIL |
| Drug class | Nucleoside Metabolic Inhibitor [EPC] |
| Manufacturer | Xiromed LLC |
| Used for | 1 INDICATIONS & USAGE Fluorouracil is indicated for the treatment of patients with: Fluorouracil is a nucleoside metabolic inhibitor indicated for the treatment of patients with • Adenocarcinoma of the Colon and Rectum ( 1.1 ) • Adenocarcinoma of the Breast ( 1.2 ) • Gastric Adenocarcinoma ( 1.3 ) • Pancreatic Adenocarcinoma ( 1.4 ) 1.1 Adenocarcinoma of the Colon and Rectum 1.2 Adenocarcinoma of the Breast 1.3 Gastric Adenocarcinoma 1.4 Pancreatic Adenocarcinoma 1.1 Adenocarcinoma of the Colon and Rectum 1.2 Adenocarcinoma of the Breast 1.3 Gastric Adenocarcinoma 1.4 Pancreatic Adenocarcinoma |
| Dosage | 2 DOSAGE & ADMINISTRATION •Fluorouracil is recommended for administration either as an intravenous bolus or as an intravenous infusion. (2.1 ) •See Full Prescribing Information for dose individualization (2.1) and dose modifications due to adverse reactions (2.6 ) •See Full Prescribing Information for recommended doses of fluorouracil for adenocarcinoma of the colon and rectum ( 2.2 ) and for recommended doses of fluorouracil as a component of a chemotherapy regimen for adenocarcinoma of the bre |
| Active ingredient(s) | FLUOROURACIL |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=19735014-c6fb-0a05-c330-2e9389c71216 |